Kyu Chan Kim, MD

Assistant Professor, Medicine

Kyu Chan Kim
617.638.4312
72 E. Concord St Evans Building

Biography

Kyu Chan Kim, MD is an Instructor of Rheumatology (Arthritis) at Chobanian and Avedisian School of Medicine. Dr. Kim attended medical school at Tulane University School of Medicine. He trained at Boston University for rheumatology fellowship. The research interests have been hip osteoarthritis and has been a recipient for Rheumatology Research Foundation. He is also one of the musculoskeletal ultrasound trained rheumatologists and has help teach many fellows earn their USSONAR certification.

Other Positions

  • Member, Arthritis & Autoimmune Diseases Research Center, Boston University

Education

  • Tulane University School of Medicine, MD
  • University of Texas at Austin, BS

Publications

  • Published on 10/1/2018

    Kim C, Nevitt M, Guermazi A, Niu J, Clancy M, Tolstykh I, Jungmann PM, Lane NE, Segal NA, Harvey WF, Lewis CE, Felson DT. Brief Report: Leg Length Inequality and Hip Osteoarthritis in the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative. Arthritis Rheumatol. 2018 10; 70(10):1572-1576. PMID: 29700988.

    Read at: PubMed
  • Published on 9/16/2016

    Willard D, Upadhyay J, Kim C, Steenkamp D. Diabetic Ketoacidosis Without Diabetes. J Clin Endocrinol Metab. 2016 Nov; 101(11):3870-3873. PMID: 27636019.

    Read at: PubMed
  • Published on 12/2/2015

    Kim C, Nevitt MC, Niu J, Clancy MM, Lane NE, Link TM, Vlad S, Tolstykh I, Jungmann PM, Felson DT, Guermazi A. Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study. BMJ. 2015; 351:h5983. PMID: 26631296.

    Read at: PubMed
  • Published on 11/1/2014

    Kim C, Linsenmeyer KD, Vlad SC, Guermazi A, Clancy MM, Niu J, Felson DT. Prevalence of radiographic and symptomatic hip osteoarthritis in an urban United States community: the Framingham osteoarthritis study. Arthritis Rheumatol. 2014 Nov; 66(11):3013-7. PMID: 25103598.

    Read at: PubMed
  • Published on 1/1/2003

    Jiang G, Yang F, Li M, Weissbecker K, Price S, Kim KC, La Russa VF, Safah H, Ehrlich M. Imatinib (ST1571) provides only limited selectivity for CML cells and treatment might be complicated by silent BCR-ABL genes. Cancer Biol Ther. 2003 Jan-Feb; 2(1):103-8. PMID: 12673129.

    Read at: PubMed

View all profiles